Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLOT vs ECF in Resectable Gastric Cancer
NCT01216644Phase 3Completed
- Sponsor
- Krankenhaus Nordwest
- Start
- Aug 2010
- Primary completion
- Mar 2017
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel, oxaliplatin in gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, sponsored by Krankenhaus Nordwest. Started Aug 2010; status: completed.
02
Drugs
docetaxeloxaliplatin
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT01216644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01216644.